Skip to content

Clinical trials

Hereditary Sensory and Autonomic Neuropathies trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Status: Unknown status Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20132
20141
20151
20162
20171
20183
20201
20225
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Zagreb2
General Hospital of Ningxia Medical University2
Peking Union Medical College Hospital2
The Third Affiliated hospital of Zhejiang Chinese Medical University2
Aristotle University Of Thessaloniki1
Bakirkoy Dr. Sadi Konuk Research and Training Hospital1
Cairo University1
Christopher Patrick Smith1
Convalife (Shanghai) Co., Ltd.1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies22
Urinary Bladder, Overactive5
Convalescence2
Ischemic Stroke2
Postoperative Cognitive Complications2
Urinary Incontinence2
Chronic Pain1
Erythromelalgia1
Lymphoma1
Nasopharyngeal Carcinoma1

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.